A quality framework for the role of invasive, non‐interventional cardiologists in the present‐day cardiac catheterization laboratory: A multidisciplinary SCAI/HFSA expert consensus statement

The present‐day cardiac catheterization laboratory (CCL) is home to varied practitioners who perform both diagnostic, interventional, and complex invasive procedures. Invasive, non‐interventional cardiologists are performing a significant proportion of the work as the CCL environment has evolved. This not only includes those who perform diagnostic‐only cardiac catheterization but also heart failure specialists who may be involved in hemodynamic assessment and in mechanical circulatory support and pulmonary hypertension specialists and transplant cardiologists. As such, the training background of those who work in the CCL is varied. While most quality metrics in the CCL are directed towards evaluation of patients who undergo traditional interventional procedures, there has not been a focus upon providing these invasive, noninterventional cardiologists, hospital/CCL administrators, and CCL directors a platform for quality metrics. This document focuses on benchmarking quality for the invasive, noninterventional practice, providing this physician community with guidance towards a patient‐centered approach to care, and offering tools to the invasive, noninterventionalists to help their professional growth. This consensus statement aims to establish a foundation upon which the invasive, noninterventional cardiologists can thrive in the CCL environment and work collaboratively with their interventional colleagues while ensuring that the highest quality of care is being delivered to all patients.

[1]  Sunil V. Rao,et al.  Length of stay following percutaneous coronary intervention: An expert consensus document update from the society for cardiovascular angiography and interventions , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[2]  M. Drazner,et al.  2017 ACC/AHA/HFSA/ISHLT/ACP Advanced Training Statement on Advanced Heart Failure and Transplant Cardiology (Revision of the ACCF/AHA/ACP/HFSA/ISHLT 2010 Clinical Competence Statement on Management of Patients With Advanced Heart Failure and Cardiac Transplant): A Report of the ACC Competency Manage , 2017, Journal of the American College of Cardiology.

[3]  J. Wildberger,et al.  Prophylactic hydration to protect renal function from intravascular iodinated contrast material in patients at high risk of contrast-induced nephropathy (AMACING): a prospective, randomised, phase 3, controlled, open-label, non-inferiority trial , 2017, The Lancet.

[4]  Sunil V. Rao,et al.  Arterial access and arteriotomy site closure devices , 2016, Nature Reviews Cardiology.

[5]  Laura Mauri,et al.  2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. , 2016, Journal of the American College of Cardiology.

[6]  Peter L Duffy,et al.  SCAI expert consensus statement: 2016 best practices in the cardiac catheterization laboratory: (Endorsed by the cardiological society of india, and sociedad Latino Americana de Cardiologia intervencionista; Affirmation of value by the Canadian Association of interventional cardiology–Association ca , 2016, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  J. Halperin,et al.  2016 ACC Lifelong Learning Competencies for General Cardiologists: A Report of the ACC Competency Management Committee. , 2016, Journal of the American College of Cardiology.

[8]  A. Shroff,et al.  Same-Day Discharge After Percutaneous Coronary Intervention: Current Perspectives and Strategies for Implementation. , 2016, JAMA cardiology.

[9]  J. Messenger,et al.  Temporal Trends in the Risk Profile of Patients Undergoing Outpatient Percutaneous Coronary Intervention: A Report from the National Cardiovascular Data Registry’s CathPCI Registry , 2016, Circulation. Cardiovascular interventions.

[10]  J. Messenger,et al.  Temporal Trends and Outcomes of Patients Undergoing Percutaneous Coronary Interventions for Cardiogenic Shock in the Setting of Acute Myocardial Infarction: A Report From the CathPCI Registry. , 2016, JACC. Cardiovascular interventions.

[11]  M. Kern,et al.  The interventional heart failure initiative: A mission statement for the next generation of invasive cardiologists , 2015, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[12]  J. Halperin,et al.  COCATS 4 Introduction. , 2015, Journal of the American College of Cardiology.

[13]  S. Kaul,et al.  COCATS 4 Task Force 11: Training in Arrhythmia Diagnosis and Management, Cardiac Pacing, and Electrophysiology. , 2015, Journal of the American College of Cardiology.

[14]  G. Dangas,et al.  COCATS 4 Task Force 10: Training in Cardiac Catheterization. , 2015, Journal of the American College of Cardiology.

[15]  P. Kirchhof,et al.  Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association , 2014, European heart journal.

[16]  D. Kolte,et al.  Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States , 2014, Journal of the American Heart Association.

[17]  J. D. de Lemos,et al.  Clinical ResearchInterventional CardiologySame-Day Discharge After Percutaneous Coronary Intervention: A Meta-Analysis , 2013 .

[18]  Andrew Wang,et al.  ACCF/AHA/SCAI 2013 Update of the Clinical Competence Statement on Coronary Artery Interventional Procedures , 2013, Circulation.

[19]  J. Jollis,et al.  ACCF/AHA/SCAI 2013 update of the clinical competence statement on coronary artery interventional procedures: a report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Revise , 2013, Journal of the American College of Cardiology.

[20]  John C. Messenger,et al.  Adoption of Radial Access and Comparison of Outcomes to Femoral Access in Percutaneous Coronary Intervention: An Updated Report from the National Cardiovascular Data Registry (2007–2012) , 2013, Circulation.

[21]  J. Blankenship,et al.  Ad Hoc percutaneous coronary intervention: A consensus statement from the society for cardiovascular angiography and interventions , 2013, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[22]  Tom Adriaenssens,et al.  Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised, controlled trial , 2013, The Lancet.

[23]  W. Abraham,et al.  Devices in the management of advanced, chronic heart failure , 2013, Nature Reviews Cardiology.

[24]  J. Messenger,et al.  The NCDR CathPCI Registry: a US national perspective on care and outcomes for percutaneous coronary intervention , 2013, Heart.

[25]  苅尾 七臣,et al.  ガイドライン解説 AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease : 2011 update , 2012 .

[26]  J. Messenger,et al.  A contemporary view of diagnostic cardiac catheterization and percutaneous coronary intervention in the United States: a report from the CathPCI Registry of the National Cardiovascular Data Registry, 2010 through June 2011. , 2012, Journal of the American College of Cardiology.

[27]  J. Messenger,et al.  The National Cardiovascular Data Registry (NCDR) Data Quality Brief: the NCDR Data Quality Program in 2012. , 2012, Journal of the American College of Cardiology.

[28]  S. Nathan,et al.  Radial Versus Femoral Access for Percutaneous Coronary Intervention: Implications for Vascular Complications and Bleeding , 2012, Current Cardiology Reports.

[29]  John Spertus,et al.  AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation. , 2011, Circulation.

[30]  Sunil V. Rao,et al.  Prevalence and outcomes of same-day discharge after elective percutaneous coronary intervention among older patients. , 2011, JAMA.

[31]  Sunil V. Rao,et al.  Radial versus femoral access for coronary angiography and intervention in patients with acute coronary syndromes (RIVAL): a randomised, parallel group, multicentre trial , 2011, The Lancet.

[32]  L. Stevenson,et al.  Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial , 2011, The Lancet.

[33]  E. Tuzcu,et al.  Interventional fellowship in structural and congenital heart disease for adults. , 2010, JACC. Cardiovascular interventions.

[34]  H. Dauerman,et al.  Vascular closure devices: the second decade. , 2007, Journal of the American College of Cardiology.

[35]  Robert West,et al.  Complications of diagnostic cardiac catheterisation: results from a confidential inquiry into cardiac catheter complications , 2005, Heart.

[36]  W. Abraham,et al.  The evolving challenge of chronic heart failure management: a call for a new curriculum for training heart failure specialists. , 2004, Journal of the American College of Cardiology.

[37]  D. Ouweneel Percutaneous mechanical circulatory support in cardiogenic shock , 2017 .